Question 1

What is the catalog number for Recombinant Annexin A7 (ANXA7)?

Accepted Answer

The catalog number for Recombinant Annexin A7 (ANXA7) is SIPE174Hu01.

Question 2

What sizes are available for Recombinant Annexin A7 (ANXA7)?

Accepted Answer

Recombinant Annexin A7 (ANXA7) is available in the following size(s): 10 µg, 50 µg, 200 µg, 1 mg, 5 mg.

Question 3

How many pack sizes does Recombinant Annexin A7 (ANXA7) come in?

Accepted Answer

Recombinant Annexin A7 (ANXA7) is available in 5 different pack sizes.

Question 4

Is Recombinant Annexin A7 (ANXA7) in stock?

Accepted Answer

Recombinant Annexin A7 (ANXA7) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 6

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Question 7

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Recombinant Annexin A7 (ANXA7)

Product Specifications

Gene Aliases

Organism

Source

Applications

Purity

Host or Source

Species

Available Sizes

Frequently Asked Questions

Explore Other Products

AFP (Alpha Fetoprotein) (C3), 1mg/mL

GPR177 (WLS) Rabbit Polyclonal Antibody

Phosphoric Acid Silver Salt

Syntaxin 18 (STX18) Mouse Monoclonal Antibody [Clone ID: OTI2C4]

IKK alpha (CHUK) (NM_001278) Human Over-expression Lysate

MRPS18A Human Gene Knockout Kit (CRISPR)